Pancreaticogastrostomy for high-risk gland after pancreaticoduodenectomy: an eligible choice?
Hu
Yang Sun
YS
Feng
Dou Ke
DK
Ying
Wang Hai
WH
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage; D000230:Adenocarcinoma / Q000601:surgery; D014670:Ampulla of Vater; D000714:Anastomosis, Surgical; D001650:Bile Duct Neoplasms / Q000601:surgery; D003138:Common Bile Duct Neoplasms / Q000601:surgery; D005765:Gastrointestinal Agents / Q000008:administration & dosage; D005774:Gastrostomy; D006801:Humans; D015282:Octreotide / Q000008:administration & dosage; D010185:Pancreatic Fistula / Q000209:etiology / Q000517:prevention & control*; D010190:Pancreatic Neoplasms / Q000601:surgery*; D010193:Pancreaticojejunostomy; D050500:Pancreatitis, Chronic / Q000601:surgery; D000077402:Pantoprazole; D054328:Proton Pump Inhibitors / Q000008:administration & dosage; D013536:Suture Techniques
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D005765:Gastrointestinal Agents; D054328:Proton Pump Inhibitors; D000077402:Pantoprazole; D015282:Octreotide